These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 11305998)
1. Coronary vasoconstriction after coronary angioplasty is attenuated by endothelin a receptor antagonism. Kyriakides ZS; Kremastinos DT; Psychari SN; Kolettis T; Sbarouni E; Webb DJ Am J Cardiol; 2001 Apr; 87(8):1011-3; A5. PubMed ID: 11305998 [No Abstract] [Full Text] [Related]
2. Usefulness of endothelin(A) receptor antagonists for the prevention of in-stent restenosis in patients with stable angina pectoris or silent myocardial ischemia. Kyriakides ZS; Psychari SN; Kolettis TM; Georgiadis M; Antoniadis A; Kremastinos DT Am J Cardiol; 2003 Feb; 91(4):476-9. PubMed ID: 12586272 [No Abstract] [Full Text] [Related]
3. Acute endothelin-A receptor antagonism prevents normal reduction of myocardial ischemia on repeated balloon inflations during angioplasty. Kyriakides ZS; Kremastinos DT; Kolettis TM; Tasouli A; Antoniadis A; Webb DJ Circulation; 2000 Oct; 102(16):1937-43. PubMed ID: 11034942 [TBL] [Abstract][Full Text] [Related]
4. Effect of estrogen on coronary vasoconstriction in patients undergoing coronary angioplasty. Lee TM; Chou TF; Tsai CH Int J Cardiol; 2005 Jun; 101(3):465-72. PubMed ID: 15907416 [TBL] [Abstract][Full Text] [Related]
5. Oestrogen attenuates coronary vasoconstriction after angioplasty: role of endothelin-1. Lee TM; Su SF; Tsai CH Eur J Clin Invest; 2002 Mar; 32(3):141-7. PubMed ID: 11895463 [TBL] [Abstract][Full Text] [Related]
6. Effects of ketanserin on epicardial coronary arteries after coronary angioplasty in patients with stable angina. Tousoulis D; Davies G; Tentolouris C; Apostolopoulos T; Kyriakides M; Toutouzas P Eur Heart J; 1994 Jul; 15(7):922-7. PubMed ID: 7925513 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Awane-Igata Y; Ikeda S; Watanabe T Br J Pharmacol; 1997 Feb; 120(3):516-22. PubMed ID: 9031758 [TBL] [Abstract][Full Text] [Related]
8. [Changes of activity of the endothelial system in experimental heart failure]. Popovich MI; Kobets VA; Todirash MP; Ivanov VM; Popovich IM; Chebanu NV; Moraru IL; Chebanu LM Kardiologiia; 2005; 45(8):33-6. PubMed ID: 16091638 [TBL] [Abstract][Full Text] [Related]
9. Inhomogeneous vasomotor effects of moderate selective and non-selective endothelin-receptor blockade in stable coronary artery disease. Wexberg P; Sperker W; Morgenthaler NG; Heinzl H; Adlbrecht C; Plass C; Glogar HD; Lang IM; Neunteufl T Heart; 2009 Aug; 95(15):1258-64. PubMed ID: 19414437 [TBL] [Abstract][Full Text] [Related]
10. Local changes in the plasma endothelin level in the coronary artery immediately after percutaneous transluminal coronary angioplasty. Vojácek J; Lisý O; Simek S; Kmonícek P; Rohác J; Jáchymová M; Jindra A Cardiology; 1997; 88(1):1-5. PubMed ID: 8960617 [TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics. Dupuis J Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309 [TBL] [Abstract][Full Text] [Related]
12. Impact of coronary angioplasty on coronary vasodilator response of normal nondilated coronary arteries in patients with stable angina. Foley JB; Watson KR; Chisholm RJ Am J Cardiol; 1995 May; 75(15):1070-1. PubMed ID: 7747693 [No Abstract] [Full Text] [Related]
13. Tissue concentrations of endothelins and functional effects of endothelin-receptor activation in human arteries and veins. Holm P; Franco-Cereceda A J Thorac Cardiovasc Surg; 1996 Aug; 112(2):264-72. PubMed ID: 8751489 [TBL] [Abstract][Full Text] [Related]
14. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Zhang Y; Oliver JR; Horowitz JD Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310 [TBL] [Abstract][Full Text] [Related]
15. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ Hypertension; 2009 Jul; 54(1):113-9. PubMed ID: 19506099 [TBL] [Abstract][Full Text] [Related]
17. Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischaemia. Kyriakides ZS; Markianos M; Iliodromitis EK; Kremastinos DT Eur Heart J; 1995 Jul; 16(7):894-8. PubMed ID: 7498202 [TBL] [Abstract][Full Text] [Related]
18. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006 [TBL] [Abstract][Full Text] [Related]